Cytek Biosciences, Inc. Net Income Loss

Quick Answer

Cytek Biosciences, Inc. reported Net Income Loss of $2.48 million for the year ending 2022.

  • Cytek Biosciences, Inc. showed a decrease of -17.9% in Net Income Loss from 2021 to 2022.
  • This data is from Cytek Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 1, 2023.
  • XBRL data for this metric is available from 2020 to 2022 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 3 years of available data (2020 to 2022), Cytek Biosciences, Inc.'s Net Income Loss has declined by 87.2%.
  • Historical annual values: Fiscal year 2022: $2.48 million | Fiscal year 2021: $3.03 million | Fiscal year 2020: $19.41 million.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: